Cargando…
Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers
Deposition of amyloid in the heart can lead to cardiac dilation and impair its pumping ability. This ultimately leads to heart failure with worsening symptoms of breathlessness and fatigue due to the progressive loss of elasticity of the myocardium. Biomarkers linked to the clinical deterioration ca...
Autores principales: | Li, Wenguang, Lazarus, Alan, Gao, Hao, Martinez-Naharro, Ana, Fontana, Marianna, Hawkins, Philip, Biswas, Swethajit, Janiczek, Robert, Cox, Jennifer, Berry, Colin, Husmeier, Dirk, Luo, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203577/ https://www.ncbi.nlm.nih.gov/pubmed/32425806 http://dx.doi.org/10.3389/fphys.2020.00324 |
Ejemplares similares
-
Atrial Involvement in Cardiac Amyloidosis: Beyond Dilatation
por: Fontana, Marianna, et al.
Publicado: (2020) -
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020) -
Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023) -
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020) -
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)